1696 — Sisram Medical Balance Sheet
0.000.00%
- HK$2.19bn
- HK$2.24bn
- $349.11m
- 77
- 68
- 81
- 91
Annual balance sheet for Sisram Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 116 | 153 | 81.4 | 70.5 | 71.8 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 47.5 | 69.9 | 80.4 | 83.5 | 84.5 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 205 | 298 | 251 | 257 | 249 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 46.2 | 45.5 | 52.2 | 62.9 | 59.5 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 432 | 530 | 556 | 614 | 627 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 54.8 | 83.6 | 80.1 | 88.3 | 95.5 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 99.9 | 128 | 125 | 161 | 163 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 332 | 402 | 431 | 452 | 464 |
| Total Liabilities & Shareholders' Equity | 432 | 530 | 556 | 614 | 627 |
| Total Common Shares Outstanding |